The company’s largest investor, billionaire publican Bruce Mathieson, says revenue is in “absolute free fall”. The retailer holds its annual meeting on Tuesday.
Endeavour Group, owner of Dan Murphy’s, BWS and 354 hotels, generated overall sales growth of 2.1 per cent in the past three months.
Mr Donohue made the comments as Endeavour disclosed sales growth across its business of 2.1 per cent in the 14 weeks to October 1. The company operates 354 hotels and the Dan Murphy’s and BWS liquor chains.The company told investors on Monday that retailing revenues had increased 1.9 per cent in that period to $2.54 billion while hotel revenues had grown 2.8 per cent to $553 million. Despite the growth, both divisions reported sales lower than many brokers had expected in the quarter.
Endeavour shares were down 2 per cent by the early afternoon, trading at $4.92. They have fallen some 27 per cent over the past six months. Mr Donohue said there had been a slowdown in sales in August and in the lead-up to Father’s Day in the liquor stores, but trading had started picking up again. “Momentum trended up again through the last two weeks in September, and this has continued into the second quarter,” he added.
United Kingdom Latest News, United Kingdom Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
BHP ASX: BHP floats turning Mt Arthur coal mine into hydropower projectThe mining giant is scheduled to close the Hunter operation in 2030. It has suggested the site could be used for clean energy generation rather than grazing.
Read more »
WHC ASX: Whitehaven’s coking coal buy to send earnings up 93pc, Citi saysThe investment bank’s brokers increased their price target on the miner’s shares despite the $5b deal being opposed by the company’s largest shareholder.
Read more »
Middle East war fears set markets on edge, ASX to fall sharplyFears of an escalation of the conflict pushed oil prices higher ahead of rate decisions from central banks in Japan, the US and the UK.
Read more »
CSL, RMD ASX: Obesity drugs: beware of the hypeResMed and CSL have been hit hard by the Ozempic and Wegovy wave, but the reality is that no one knows how the GLP-1 drug landscape will play out.
Read more »
Rival Offer Emerges for ASX-Listed DivergerAsset finance broking group, COG, has made a rival offer for ASX-listed licensee services group, Diverger, which had already agreed to be acquired by Count Limited. The offer is at a premium to Count's offer and values Diverger's equity at $56.4 million.
Read more »
ASX to drop 1 per cent amid fears over Middle East conflictThe ASX is set to open lower, after a fall on Wall Street brought the S&P 500 10 per cent below its July peak, putting the benchmark index into a correction.
Read more »